These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22469977)

  • 1. Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model.
    Alikhani N; Ferguson RD; Novosyadlyy R; Gallagher EJ; Scheinman EJ; Yakar S; LeRoith D
    Oncogene; 2013 Feb; 32(8):961-7. PubMed ID: 22469977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing vimentin expression decreases pulmonary metastases in a pre-diabetic mouse model of mammary tumor progression.
    Zelenko Z; Gallagher EJ; Tobin-Hess A; Belardi V; Rostoker R; Blank J; Dina Y; LeRoith D
    Oncogene; 2017 Mar; 36(10):1394-1403. PubMed ID: 27568979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes.
    Ferguson RD; Novosyadlyy R; Fierz Y; Alikhani N; Sun H; Yakar S; Leroith D
    Breast Cancer Res; 2012 Jan; 14(1):R8. PubMed ID: 22226054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia.
    Gallagher EJ; Fierz Y; Vijayakumar A; Haddad N; Yakar S; LeRoith D
    Oncogene; 2012 Jul; 31(27):3213-22. PubMed ID: 22037215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast-cancer-associated metastasis is significantly increased in a model of autoimmune arthritis.
    Das Roy L; Pathangey LB; Tinder TL; Schettini JL; Gruber HE; Mukherjee P
    Breast Cancer Res; 2009; 11(4):R56. PubMed ID: 19643025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ErbB3 ablation impairs PI3K/Akt-dependent mammary tumorigenesis.
    Cook RS; Garrett JT; Sánchez V; Stanford JC; Young C; Chakrabarty A; Rinehart C; Zhang Y; Wu Y; Greenberger L; Horak ID; Arteaga CL
    Cancer Res; 2011 Jun; 71(11):3941-51. PubMed ID: 21482676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers.
    Weng D; Penzner JH; Song B; Koido S; Calderwood SK; Gong J
    Breast Cancer Res; 2012 Jan; 14(1):R18. PubMed ID: 22277639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior.
    Borowsky AD; Namba R; Young LJ; Hunter KW; Hodgson JG; Tepper CG; McGoldrick ET; Muller WJ; Cardiff RD; Gregg JP
    Clin Exp Metastasis; 2005; 22(1):47-59. PubMed ID: 16132578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation.
    Hulit J; Suyama K; Chung S; Keren R; Agiostratidou G; Shan W; Dong X; Williams TM; Lisanti MP; Knudsen K; Hazan RB
    Cancer Res; 2007 Apr; 67(7):3106-16. PubMed ID: 17409417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
    Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
    J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mena deficiency delays tumor progression and decreases metastasis in polyoma middle-T transgenic mouse mammary tumors.
    Roussos ET; Wang Y; Wyckoff JB; Sellers RS; Wang W; Li J; Pollard JW; Gertler FB; Condeelis JS
    Breast Cancer Res; 2010; 12(6):R101. PubMed ID: 21108830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis.
    Novitskiy SV; Forrester E; Pickup MW; Gorska AE; Chytil A; Aakre M; Polosukhina D; Owens P; Yusupova DR; Zhao Z; Ye F; Shyr Y; Moses HL
    Breast Cancer Res; 2014 Oct; 16(5):425. PubMed ID: 25280532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
    Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL
    Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways.
    Nasser MW; Qamri Z; Deol YS; Ravi J; Powell CA; Trikha P; Schwendener RA; Bai XF; Shilo K; Zou X; Leone G; Wolf R; Yuspa SH; Ganju RK
    Cancer Res; 2012 Feb; 72(3):604-15. PubMed ID: 22158945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and angiogenesis.
    David M; Ribeiro J; Descotes F; Serre CM; Barbier M; Murone M; Clézardin P; Peyruchaud O
    Int J Oncol; 2012 Apr; 40(4):1133-41. PubMed ID: 22200658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis.
    Calvo A; Catena R; Noble MS; Carbott D; Gil-Bazo I; Gonzalez-Moreno O; Huh JI; Sharp R; Qiu TH; Anver MR; Merlino G; Dickson RB; Johnson MD; Green JE
    Oncogene; 2008 Sep; 27(40):5373-84. PubMed ID: 18504437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting heparanase to the mammary epithelium enhances mammary gland development and promotes tumor growth and metastasis.
    Boyango I; Barash U; Fux L; Naroditsky I; Ilan N; Vlodavsky I
    Matrix Biol; 2018 Jan; 65():91-103. PubMed ID: 28916201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model.
    Xin X; Majumder M; Girish GV; Mohindra V; Maruyama T; Lala PK
    Lab Invest; 2012 Aug; 92(8):1115-28. PubMed ID: 22641101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
    Dey JH; Bianchi F; Voshol J; Bonenfant D; Oakeley EJ; Hynes NE
    Cancer Res; 2010 May; 70(10):4151-62. PubMed ID: 20460524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression.
    Hutchinson J; Jin J; Cardiff RD; Woodgett JR; Muller WJ
    Mol Cell Biol; 2001 Mar; 21(6):2203-12. PubMed ID: 11238953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.